Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2004-10-29 | Robert B. Kay 64 Class II 2003 Since 2002, Mr. Kay served as Chairman of Paxis Pharmaceuticals, Inc. Prior to that, he was a founding partner of the New York-based law firm of Kay, Collyer & Boose LLP. Mr. Kay is the brother of E. Gerald Kay. ... No compensation was paid to any director for his or her services to the Board of Directors or any committee. |
| 2005-10-28 | Robert B. Kay 65 Class II 2003 Served as a director of the Company since 2003. Since 2002 he has served as Chairman of Paxis Pharmaceuticals, Inc. |
| 2006-11-06 | Robert B. Kay ................................................ 66 Class II 2003 Served as a director of the Company since 2003. Since 2002 served as Chairman of Paxis Pharmaceuticals, Inc. Prior to that he was a founding partner of the New York- ... The only standing committee of the Board of Directors is the Audit Committee, whose members are Messrs. Canarick, Chang, and Kraljevic and Dr. Yusibov. |
| 2007-10-30 | Robert B. Kay, 67, Director. No director compensation as he is an executive officer. |
| 2008-10-28 | Robert B. Kay 68 Class II 2003 Served as a director of the Company since 2003. Since 2008 served as Chairman and Director of iBioPharma, Inc. since 2002 served as Chairman of Paxis Pharmaceuticals, Inc. Prior to that he was a founding partner of the New York-based law firm of Kay, Collyer & Boose LLP. Mr. Kay is the brother of E.Gerald Kay. Summary Compensation Table for 2008 Robert B. Kay 2008 46497 -0- 48446 29929 -0- -0- 120000 244872 President and Chief Executive Officer, InB:Paxis Pharmaceuticals, Inc. and iBioPharma, Inc. |
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-30 | Robert B. Kay is our Chief Executive Officer and has served in such role since the consummation of the Taylor Acquisition in March 2018. |
| 2019-04-30 | Robert B. Kay is our Chief Executive Officer and has served in such role since the consummation of the Filament Acquisition in March 2018. |
| 2020-04-29 | Robert B. Kay 58 CEO, Lifetime Brands, Inc. 2018 Exec |
| 2021-04-29 | Robert B. Kay is our Chief Executive Officer and has served in such role since the consummation of the Filament Acquisition in March 2018... Mr. Kay has been a member of the operating partner network of Centre Partners Management, LLC. |
| 2022-04-28 | Robert B. Kay 60 CEO, Lifetime Brands, Inc. 2018 Exec, ESG Robert B. Kay is our ChiefExecutive Officer and has served in such role since the consummation of the Filament Acquisition in March 2018. |
| 2023-04-27 | Robert B. Kay is our Chief Executive Officer and has served in such role since the consummation of the Filament Acquisition in March 2018. Mr. Kay previously served as the Chairman and Chief Executive Officer of Filament from 2012 to 2018. Mr. Kay began his career at Deloitte & Touche where he spent six years as a management consultant. |
| 2024-04-25 | Robert B. Kay 62 CEO, Lifetime Brands, Inc. Joined Board 2018. Committees: Exec, ESG. No director compensation listed as he is an employee. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22